The Rare Neurodegenerative Disease Treatment Market region analysis shows North America leading due to strong healthcare infrastructure, advanced clinical trial networks, and higher disease awareness. Europe follows, supported by orphan drug incentives and patient advocacy programs. Asia-Pacific demonstrates high growth potential driven by urbanization, rising healthcare investment, and...